Results 81 to 90 of about 53,957 (281)

Utility of new image-derived biomarkers for autosomal dominant polycystic kidney disease prognosis using automated instance cyst segmentation

, 2023
New image-derived biomarkers for patients affected by autosomal dominant polycystic kidney disease are needed to improve current clinical management. The measurement of total kidney volume (TKV) provides critical information for clinicians to drive care ...
Kyongtae T. Bae, Gregory, AV, Bae, KT, Yu, ASL, Mrug, M, Erickson, BJ, Bhavya Poudyal, William M. Bennett, Harris, PC, Alan S.L. Yu, Peter C. Harris, Douglas P. Landsittel, Timothy L. Kline, Chebib, F, Vicente E. Torres, Michal Mrug, Bradley J. Erickson, Poudyal, B, Chapman, AB, Rahbari-Oskoui Frederic, Frederic, RO, Adriana V. Gregory, Arlene B. Chapman, Torres, VE, Holmes, H, Kline, TL, Landsittel, DP, Bennett, WM, Fouad T. Chebib, Heather L. Holmes   +29 more
core   +1 more source

Quantitative Susceptibility Mapping of Kidney Stones: An Ex Vivo MRI Phantom Study

Magnetic Resonance in Medicine, EarlyView.
ABSTRACT Purpose To visualize and characterize the five most common kidney stone types based on their magnetic susceptibilities in MRI using QSM. Methods Three water‐based agar phantoms were constructed, containing a total of 53 ex vivo kidney stones of varying types and sizes.
Lion H. Mücke, Frederik B. Laun, Ruben de Figueiredo Cardoso, Guillaume Flé, Jennifer Lorenz, Alexander Fichte, Michael Uder, Nadine Bayerl, Jannis Hanspach   +8 more
wiley   +1 more source

Hereditary Renal Cystic Diseases

Turkish Journal of Nephrology, 2019
Polycystic kidney disease is one of the most common reasons of end stage renal failure. Polycystic kidney disease may result from many etiological factors, but frequently arises hereditarily.
Alper UZAK, M. Deniz AYLI
doaj  

Should a paediatrician perform abdominal ultrasonography inchildren of parents with polycystic kidney disease?

, 2016
Autosomal dominant polycystic kidney disease produces symptoms mainly in adulthood. Renal cysts and/or elevated blood pressure can be the first signs of the disease in children.
Krzysztof Wróblewski, Marcin Tkaczyk, Tkaczyk, Marcin, Afshari, Susan, Katarzyna Młudzik, Wróblewski, Krzysztof, Młudzik, Katarzyna, Piotr Grzelak, Grzelak, Piotr, Susan Afshari   +9 more
core   +1 more source

Kidney Function and Plasma Copeptin Levels in Healthy Kidney Donors and Autosomal Dominant Polycystic Kidney Disease Patients [PDF]

, 2014
Background and objectives Plasma copeptin, a marker of arginine vasopressin, is elevated in patients with autosomal dominant polycystic kidney disease and predicts disease progression.
Else van den Berg, Debbie Zittema, Meijer, Esther, Bakker, Stephan J. L., Franssen, Casper F. M., Franssen, Casper F. M.; id_orcid, Casper F.M. Franssen, Gerjan Navis, Muller Kobold, Anneke C. ; id_orcid, Paul E. de Jong, Stephan J.L. Bakker, Navis, Gerjan, van den Berg, Else, de Jong, Paul E., Esther Meijer, Zittema, Debbie, Bakker, Stephan J. L.; id_orcid, Boertien, Wendy E., Wendy E. Boertien, Anneke C. Muller Kobold, Ron T. Gansevoort, Gansevoort, Ron T., Muller Kobold, Anneke C.   +22 more
core   +1 more source

SURMOUNT‐REAL UK: A Pragmatic Randomized Clinical Trial to Assess the Effectiveness of Tirzepatide in Adults With Obesity

Obesity, EarlyView.
ABSTRACT Objective SURMOUNT‐REAL UK will evaluate the effectiveness of tirzepatide when offered in addition to standard‐of‐care (SoC) in adults with Class I obesity (BMI ≥ 30 and ≤ 34.9 kg/m2) and without diabetes in a UK primary care setting. Methods A 5‐year, phase 4, multicenter, open‐label, pragmatic randomized clinical trial is enabled through ...
Martin K. Rutter, Julie Mount, J. Martin Gibson, Joanne Webb, Cheryl Marler, Catherine Reed, Mugdha Gore, Wenyu Ye, Elisa Gomez Valderas, John Wilding, Naveed Sattar, Melanie J. Davies, Kamlesh Khunti, Richard Haynes, Rachel L. Batterham   +14 more
wiley   +1 more source

Polycystic Kidney Disease in Cats

Veterinary Quarterly, 1998
(1998). Polycystic Kidney Disease in Cats. Veterinary Quarterly: Vol. 20, Voorjaarsdagen Congress 1998, pp. S112-S113.
J T, Bosje, T S, van den Ingh
openaire   +2 more sources

Establishing a core outcome set for autosomal dominant polycystic kidney disease: Report of the Standardized Outcomes in Nephrology–Polycystic Kidney Disease (SONG-PKD) consensus workshop [PDF]

, 2020
The omission of outcomes that are of relevance to patients, clinicians, and regulators across trials in autosomal dominant polycystic kidney disease (ADPKD) limits shared decision making. The Standardized Outcomes in Nephrology–Polycystic Kidney Disease (
Craig, Jonathan C., Shen, Jenny, Chapman, Arlene, Cho, Yeoungjee, Johnson, David W., Mustafa, Reem A., SONG-PKD Workshop Investigators, Fowler, Kevin, Torres, Vicente, Perrone, Ronald D, Perrone, Ronald D., Rastogi, Anjay, Johnson, David W, Ong, Albert C.M., Kao, Juliana Tze-Wah, Chonchol, Michel, Logeman, Charlotte, Mustafa, Reem A, Shen, Jenny I, Sharma, Ankit, Viecelli, Andrea K, Ju, Angela, Gansevoort, Ron T, Tong, Allison, Baron, David, Sautenet, Benedicte, Ahn, Curie, Shen, Jenny I., Manera, Karine E., Rangan, Gopala, Au, Eric, Viecelli, Andrea K., Odland, Dwight, Gutman, Talia, Craig, Jonathan C, Gansevoort, Ron T., Coolican, Helen, Harris, Tess, Ong, Albert C M, Tze-Wah Kao, Juliana, El-Damanawi, Ragada, Pei, York, Manera, Karine E   +42 more
core   +1 more source

Cross Sectional Study of Prenatal Diagnosis Uptake Among Individuals With Genetic Conditions

Prenatal Diagnosis, EarlyView.
ABSTRACT Objective Prenatal diagnostic genetic testing allows for early identification of significant fetal conditions and enables informed decision‐making regarding management options. The aim of this study was to assess prenatal testing practice among individuals with genetic conditions.
Ebunoluwa Ojo, Roni Zemet, Allyson Nevins, Katherine Abraham, April D. Adams   +4 more
wiley   +1 more source

Interrupted Aortic Arch in an Adult with Polycystic Kidney Disease

Case Reports in Medicine, 2013
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease and is responsible for 8–10% of patients with end-stage renal failure.
Ayşe Şeker Koçkara, Mansur Kayataş, Can Huzmeli, Ferhan Candan, Cesur Gümüş   +4 more
doaj   +1 more source